  | |||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
| Journal Home | |
| Current Issue | |
| AOP | |
| Archive | |
| |
| |
THIS ARTICLE  | |
| |
| Download PDF | |
| References | |
| |
| |
| |
| Export citation | |
| Export references | |
| |
| |
| |
| Send to a friend | |
| |
| |
| |
| More articles like this | |
| |
| |
| |
| Table of Contents | |
| | Next > | |
| |
 |
 |
| Nature 311, 406 (04 October 1984); doi:10.1038/311406d0 |
|
Bio company launch
D. MALAMUD & J. HANOUNE
Genasex Ltd, c/o University of Pennsylvania, Thomas W. Evans Museum & Dental Institute, 4001 Spruce Street, Philadelphia, Pennsylvania 19104, USA
| 1. | Dow-Jones et al., any day, any paper. |
| 2. | Nature, Index of Biotechnology Stocks, monthly reports. |
© 1984 Nature Publishing Group
Privacy Policy
